• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1800102 MK-7264 gefapixant Injection Chemical Drugs(1) Import Drug Application 2018-08-23 Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp In Review 2018-08-22 view
JXHB2000003 MK-7264 gefapixant Injection Chemical Drugs(1) Supplementary Application 2020-08-06 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd In Review 2020-08-05 view
JXHB2100015 MK-7264 gefapixant Injection Chemical Drugs(1) Supplementary Application 2021-01-27 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd In Review 2021-01-26 view
JYHB1900661 MK-7264 gefapixant Injection Chemical Drugs(1) Supplementary Application 2019-06-14 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd In Review 2019-06-13 view
JXHB2100014 MK-7264 gefapixant Injection Chemical Drugs(1) Supplementary Application 2021-01-27 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd In Review 2021-01-26 view
JYHB1900660 MK-7264 gefapixant Injection Chemical Drugs(1) Supplementary Application 2019-06-14 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd In Review 2019-06-13 view
JXHL1800101 MK-7264 gefapixant Injection Chemical Drugs(1) Import Drug Application 2018-08-23 Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp In Review 2018-08-22 view
JXHB2000004 MK-7264 gefapixant Injection Chemical Drugs(1) Supplementary Application 2020-08-06 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd In Review 2020-08-05 view